JP2023512783A5 - - Google Patents
Info
- Publication number
- JP2023512783A5 JP2023512783A5 JP2022547874A JP2022547874A JP2023512783A5 JP 2023512783 A5 JP2023512783 A5 JP 2023512783A5 JP 2022547874 A JP2022547874 A JP 2022547874A JP 2022547874 A JP2022547874 A JP 2022547874A JP 2023512783 A5 JP2023512783 A5 JP 2023512783A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- gaa
- use according
- individual
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025138630A JP2025166240A (ja) | 2020-02-08 | 2025-08-22 | ポンペ病を処置するための組成物および方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062971930P | 2020-02-08 | 2020-02-08 | |
| US62/971,930 | 2020-02-08 | ||
| US202063115975P | 2020-11-19 | 2020-11-19 | |
| US63/115,975 | 2020-11-19 | ||
| PCT/US2021/017113 WO2021159092A1 (en) | 2020-02-08 | 2021-02-08 | Compositions and methods for treating pompe disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138630A Division JP2025166240A (ja) | 2020-02-08 | 2025-08-22 | ポンペ病を処置するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512783A JP2023512783A (ja) | 2023-03-29 |
| JP2023512783A5 true JP2023512783A5 (cg-RX-API-DMAC10.html) | 2024-02-16 |
| JP7804582B2 JP7804582B2 (ja) | 2026-01-22 |
Family
ID=74853758
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547874A Active JP7804582B2 (ja) | 2020-02-08 | 2021-02-08 | ポンペ病を処置するための組成物および方法 |
| JP2025138630A Pending JP2025166240A (ja) | 2020-02-08 | 2025-08-22 | ポンペ病を処置するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025138630A Pending JP2025166240A (ja) | 2020-02-08 | 2025-08-22 | ポンペ病を処置するための組成物および方法 |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4100120A1 (en) | 2020-02-08 | 2022-12-14 | Genzyme Corporation | Compositions and methods for treating pompe disease |
| BR112022025314A2 (pt) | 2020-06-14 | 2023-01-03 | Genzyme Corp | Composições e métodos para tratamento de doença de pompe de início tardio |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| JP5137814B2 (ja) | 2005-04-06 | 2013-02-06 | ジェンザイム・コーポレーション | 治療ターゲティングのための酸不安定リンカーを介するｐｅｇおよびポリシアルリソソーム酵素のコンジュゲート |
| CN102978185B (zh) * | 2007-01-18 | 2015-02-11 | 建新公司 | 包含氨基氧基基团的寡糖及其轭合物 |
| EP3608330B1 (en) * | 2008-12-16 | 2022-11-09 | Genzyme Corporation | Synthetic intermediates for preparing oligosaccharide-protein conjugates |
| AU2012256281B2 (en) | 2011-05-16 | 2017-06-15 | Genzyme Corporation | Induction of immune tolerance by using methotrexate |
| EP3270894B1 (en) * | 2015-03-19 | 2021-02-24 | Translate Bio, Inc. | Mrna therapy for pompe disease |
| IL299470B2 (en) * | 2015-12-30 | 2026-05-01 | Amicus Therapeutics Inc | Improved acid alpha-glucosidase for the treatment of Pompe disease |
| EP4100120A1 (en) | 2020-02-08 | 2022-12-14 | Genzyme Corporation | Compositions and methods for treating pompe disease |
-
2021
- 2021-02-08 EP EP21709562.9A patent/EP4100120A1/en active Pending
- 2021-02-08 CA CA3167091A patent/CA3167091A1/en active Pending
- 2021-02-08 IL IL295415A patent/IL295415A/en unknown
- 2021-02-08 AU AU2021216055A patent/AU2021216055A1/en active Pending
- 2021-02-08 CN CN202180013438.1A patent/CN115715218A/zh active Pending
- 2021-02-08 WO PCT/US2021/017113 patent/WO2021159092A1/en not_active Ceased
- 2021-02-08 TW TW110104793A patent/TWI917351B/zh active
- 2021-02-08 BR BR112022015505A patent/BR112022015505A2/pt unknown
- 2021-02-08 MX MX2022009753A patent/MX2022009753A/es unknown
- 2021-02-08 KR KR1020227030889A patent/KR20220139936A/ko active Pending
- 2021-02-08 JP JP2022547874A patent/JP7804582B2/ja active Active
- 2021-02-08 US US17/170,667 patent/US12251430B2/en active Active
-
2022
- 2022-09-06 ZA ZA2022/09925A patent/ZA202209925B/en unknown
-
2025
- 2025-02-13 US US19/053,240 patent/US20250319166A1/en active Pending
- 2025-08-22 JP JP2025138630A patent/JP2025166240A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2626512C2 (ru) | Концентрированные белковые фармацевтические составы и их применение | |
| US12065494B2 (en) | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent | |
| ES2993153T3 (en) | Pan elr+ cxc chemokine antibodies | |
| ES2681195T3 (es) | Utilización de la proteína de fusión TACI-Ig, tal como atacicept, para la fabricación de un medicamento para el tratamiento de lupus eritematoso | |
| BR112021010789A2 (pt) | Anticorpos anti-il-36r para o tratamento de pustulose palmoplantar | |
| CN111265531A (zh) | 治疗和预防移植物抗宿主病的方法 | |
| Fudenberg | Are autoimmune diseases immunologic deficiency states? | |
| EP3856262A1 (en) | Combination therapy | |
| JP2018515493A5 (cg-RX-API-DMAC10.html) | ||
| JP2018522028A (ja) | ブルトン型チロシンキナーゼ阻害剤の組み合わせ及びそれらの使用 | |
| JP2022116305A (ja) | 抗体含有製剤 | |
| JP2024023347A (ja) | ＴＮＦα関連疾患の治療方法 | |
| Passwell et al. | Inter-mouse strain differences in macrophage function and its relationship to antibody responses | |
| Gillis et al. | Six refractory lupus patients treated with rituximab: a case series | |
| JP2003528890A5 (cg-RX-API-DMAC10.html) | ||
| Kay et al. | Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease | |
| TWI775333B (zh) | 治療癌症之方法 | |
| CN120285174A (zh) | 抗vegf抗体与parp抑制剂联合用于治疗肿瘤 | |
| ES3009417T3 (en) | Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa | |
| JP2023552773A5 (cg-RX-API-DMAC10.html) | ||
| JP4370117B2 (ja) | 化学物質過敏症治療薬 | |
| US20250230238A1 (en) | Methods and compositions for treating systemic lupus erythematous (sle) | |
| WO2025209479A1 (en) | Methods of treatment of immune thrombocytopenia using sovleplenib | |
| DE LIA et al. | Digoxin therapy in the fetus | |
| US20250223356A1 (en) | Methods and compositions for treating relapsing multiple sclerosis |